Unknown

Dataset Information

0

Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.


ABSTRACT: Fanconi anemia (FA) patients develop bone marrow (BM) failure or leukemia. One standard care for these devastating complications is hematopoietic stem cell transplantation. We identified a group of mesenchymal stromal cells (MSCs)-derived metabolites, glycerophospholipids, and their endogenous inhibitor, 5-(tetradecyloxy)-2-furoic acid (TOFA), as regulators of donor hematopoietic stem and progenitor cells. We provided two pieces of evidence that TOFA could improve hematopoiesis-supporting function of FA MSCs: (a) limiting-dilution cobblestone area-forming cell assay revealed that TOFA significantly increased cobblestone colonies in Fanca-/- or Fancd2-/- cocultures compared to untreated cocultures. (b) Competitive repopulating assay using output cells collected from cocultures showed that TOFA greatly alleviated the abnormal expansion of the donor myeloid (CD45.2+Gr1+Mac1+) compartment in both peripheral blood and BM of recipient mice transplanted with cells from Fanca-/- or Fancd2-/- cocultures. Furthermore, mechanistic studies identified Tlr4 signaling as the responsible pathway mediating the effect of glycerophospholipids. Thus, targeting glycerophospholipid biosynthesis in FA MSCs could be a therapeutic strategy to improve hematopoiesis and stem cell transplantation.

SUBMITTER: Amarachintha S 

PROVIDER: S-EPMC4618082 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3962166 | BioStudies
2018-01-01 | S-EPMC5918239 | BioStudies
2020-01-01 | S-EPMC7556119 | BioStudies
1000-01-01 | S-EPMC5914729 | BioStudies
2018-01-01 | S-EPMC5973476 | BioStudies
2019-01-01 | S-EPMC6698648 | BioStudies
2009-01-01 | S-EPMC2665210 | BioStudies
1000-01-01 | S-EPMC5288211 | BioStudies
2020-01-01 | S-EPMC7102982 | BioStudies
1000-01-01 | S-EPMC2710946 | BioStudies